MICROOPTX INC has a total of 35 patent applications. It decreased the IP activity by 72.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology, macromolecular chemistry and polymers and basic materials chemistry are PERFECSEAL INC, SISTERS OF PROVIDENCE IN OREGO and POLYNOVO BIOMATERIALS PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Australia | 5 | |
#5 | Canada | 5 | |
#6 | China | 4 |
# | Technology | |
---|---|---|
#1 | Object sterilising | |
#2 | Implantable devices | |
#3 | Diagnosis and surgery | |
#4 | Adhesives | |
#5 | Special macromolecular compounds | |
#6 | Special macromolecular compounds | |
#7 | Layered products | |
#8 | Compounding processes | |
#9 | Making microstructural devices | |
#10 | Spectacles |
# | Name | Total Patents |
---|---|---|
#1 | Brown J David | 23 |
#2 | Cohen Edward Aaron | 15 |
#3 | Martin Roy Christian | 14 |
#4 | Pulling Christopher Clark | 11 |
#5 | Bazor Ben | 7 |
#6 | Yang Gaomai | 7 |
#7 | Pan Tingrui | 7 |
#8 | Martin Christopher Thomas | 6 |
#9 | Voce Daniel Charles | 2 |
#10 | Cohen Aaron | 2 |
Publication | Filing date | Title |
---|---|---|
US2020297530A1 | Implantable ocular drug delivery devices and methods | |
WO2019118231A1 | Implantable ocular glucose sensor devices and methods | |
CN110088158A | Polymeric device and manufacturing method | |
AU2017293767A1 | Glaucoma treatment devices and methods | |
US2018333085A1 | Aqueous humor monitoring devices and methods | |
WO2017059272A1 | Dry eye treatment devices and methods | |
AU2015374033A1 | Glaucoma treatment devices and methods |